Chronic administration of the FAAH inhibitor URB597, which would increase AEA levels, has been shown to reduce anxiety-like effects and to display antidepressant-like actions in a CUS rat model; effects that were prevented by a CB1R-selective antagonist SR141761A [106]. The gene discussed is CNR1; the disease is Anxiety.